Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Kommoss

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Cancer Research and Clinical Oncology|August 7, 2019
Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancerSabine Heublein, Michael S Anglesio, Frederik Marmé, et al.
Archives of Gynecology and Obstetrics|July 14, 2022
Atypical course of a caesarean scar pregnancyKatharina Schlammerl, Stefan Kommoss, Bernhard Krämer, et al.
British Journal of Cancer|September 16, 2016
Ovarian carcinoma diagnosis: the clinical impact of 15 years of changeStefan Kommoss, C Blake Gilks, Andreas du Bois, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
Surgical Technology International|January 27, 2021
Peritoneal Adhesions and their Prevention - Current TrendsBernhard Krämer, Felix Neis, Sara Y Brucker, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Gynecologic Oncology|March 7, 2006
Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)Stefan Kommoss, Andreas du Bois, Dietmar Schmidt, et al.
Breast Cancer Research and Treatment|February 26, 2016
Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence scoreAndreas D Hartkopf, Markus Wallwiener, Stefan Kommoss, et al.
Gynecologic Oncology|March 26, 2005
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxelFriedrich Kommoss, Stefan Kommoss, Dietmar Schmidt, et al.
Cancers|September 15, 2020
A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?Simone Marnitz, Till Walter, Birgid Schömig-Markiefka, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Cancer Research and Clinical Oncology|August 7, 2019
Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancerSabine Heublein, Michael S Anglesio, Frederik Marmé, et al.
Archives of Gynecology and Obstetrics|July 14, 2022
Atypical course of a caesarean scar pregnancyKatharina Schlammerl, Stefan Kommoss, Bernhard Krämer, et al.
British Journal of Cancer|September 16, 2016
Ovarian carcinoma diagnosis: the clinical impact of 15 years of changeStefan Kommoss, C Blake Gilks, Andreas du Bois, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
Surgical Technology International|January 27, 2021
Peritoneal Adhesions and their Prevention - Current TrendsBernhard Krämer, Felix Neis, Sara Y Brucker, et al.
Expert Review of Anticancer Therapy|July 11, 2009
Role of cytoreductive surgery in recurrent ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Gynecologic Oncology|March 7, 2006
Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)Stefan Kommoss, Andreas du Bois, Dietmar Schmidt, et al.
Breast Cancer Research and Treatment|February 26, 2016
Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence scoreAndreas D Hartkopf, Markus Wallwiener, Stefan Kommoss, et al.
Gynecologic Oncology|March 26, 2005
Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxelFriedrich Kommoss, Stefan Kommoss, Dietmar Schmidt, et al.
Cancers|September 15, 2020
A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?Simone Marnitz, Till Walter, Birgid Schömig-Markiefka, et al.
Pageof 16